- Home
- OMI vs ADPT Comparison
OMI vs ADPT Comparison
Compare OMI & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- ADPT
- Stock Information
- Founded
- OMI 1882
- ADPT 2009
- Country
- OMI United States
- ADPT United States
- Employees
- OMI N/A
- ADPT N/A
- Industry
- OMI Medical Specialities
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OMI Health Care
- ADPT Health Care
- Exchange
- OMI Nasdaq
- ADPT Nasdaq
- Market Cap
- OMI 1.0B
- ADPT 1.2B
- IPO Year
- OMI N/A
- ADPT 2019
- Fundamental
- Price
- OMI $9.52
- ADPT $7.73
- Analyst Decision
- OMI Hold
- ADPT Buy
- Analyst Count
- OMI 7
- ADPT 5
- Target Price
- OMI $16.07
- ADPT $9.10
- AVG Volume (30 Days)
- OMI 2.5M
- ADPT 1.9M
- Earning Date
- OMI 05-02-2025
- ADPT 02-11-2025
- Dividend Yield
- OMI N/A
- ADPT N/A
- EPS Growth
- OMI N/A
- ADPT N/A
- EPS
- OMI N/A
- ADPT N/A
- Revenue
- OMI $10,700,883,000.00
- ADPT $178,957,000.00
- Revenue This Year
- OMI $3.58
- ADPT $21.21
- Revenue Next Year
- OMI $2.57
- ADPT $21.98
- P/E Ratio
- OMI N/A
- ADPT N/A
- Revenue Growth
- OMI 3.55
- ADPT 5.10
- 52 Week Low
- OMI $6.07
- ADPT $2.28
- 52 Week High
- OMI $28.35
- ADPT $8.95
- Technical
- Relative Strength Index (RSI)
- OMI 51.27
- ADPT 45.83
- Support Level
- OMI $9.50
- ADPT $6.79
- Resistance Level
- OMI $10.43
- ADPT $8.49
- Average True Range (ATR)
- OMI 0.67
- ADPT 0.74
- MACD
- OMI 0.47
- ADPT -0.17
- Stochastic Oscillator
- OMI 79.59
- ADPT 46.00
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).